Cancer
BCL-2 208-217 (HLA-A*02:01)
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11081_1
Description
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-2-derived peptide of PLFDFSWLSL sequence covering 208-217 and A*02:01 molecule.
TechData
| Sequence: | PLFDFSWLSL |
| Gene: | BAD |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Bcl2-associated agonist of cell death |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |